Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,486 INR | +3.03% | +5.48% | +19.05% |
07:10am | Cipla Arm Gets US FDA Final Nod for Lanreotide Injection | MT |
May. 17 | Cipla Limited Approves the Appointment of Dr. Balram Bhargava as an Independent Director | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.05% | 13.98B | |
+20.83% | 44.39B | |
+20.08% | 22.46B | |
+18.63% | 15.04B | |
+56.22% | 13.15B | |
-10.55% | 6.89B | |
-0.05% | 6.79B | |
+14.03% | 5.71B | |
-8.87% | 5.73B | |
+6.11% | 4.69B |
- Stock Market
- Equities
- CIPLA Stock
- News Cipla Limited
- Cipla Arm Completes Acquisition of Ivia's Cosmetics, Personal-Care Marketing Business